Halflytely and Calcification - a phase IV clinical study of FDA data

Summary:

We study 285 people who take Halflytely (polyethylene glycol 3350; sodium chloride; sodium bicarbonate; potassium chloride; bisacodyl) or have Calcification. No report of Calcification is found in people who take Halflytely.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Halflytely?

Halflytely has active ingredients of polyethylene glycol 3350; sodium chloride; sodium bicarbonate; potassium chloride; bisacodyl. eHealthMe is studying from 251 Halflytely users. Check the latest studies of Halflytely.

What is Calcification?

Calcification: no further information found. Check the latest studies of Calcification.

On Jun, 17, 2026

No report is found.

Do you take Halflytely and have Calcification?

- Check whether Calcification is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Halflytely:

Halflytely (251 reports)

Calcification treatments and more:

Calcification (34 reports)

How severe was Calcification and when was it recovered:

Calcification in Halflytely

Expand to all the drugs that have ingredients of polyethylene glycol 3350; sodium chloride; sodium bicarbonate; potassium chloride; bisacodyl:

Calcification and drugs with ingredients of polyethylene glycol 3350; sodium chloride; sodium bicarbonate; potassium chloride; bisacodyl

Browse all side effects of Halflytely:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Calcification:

Calcification

Browse all the conditions that are associated with Calcification:

Calcification

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350; sodium chloride; sodium bicarbonate; potassium chloride; bisacodyl (the active ingredients of Halflytely) and Halflytely (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.